China Prepares to Adjust 2026 Growth Target While Facing Political Crossroads Ahead of Two Sessions March 3, 2026 — 07:10
Merz’s Balancing Act in China: Navigating Diplomatic Waters with Prudent Caution March 1, 2026 — 21:20
China’s Leading Innovative Drug Company Makes Strides, Amasses Over $20 Billion in the U.S. March 1, 2026 — 00:30
China modifies assessment criteria away from pure GDP growth, reshaping perspectives February 28, 2026 — 20:50
US House China Investigation Committee Reveals Chinese Aerospace Activities in Latin America February 28, 2026 — 06:15